These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 11884266)

  • 1. Obesity-related hypertension: role of the sympathetic nervous system, insulin, and leptin.
    Masuo K
    Curr Hypertens Rep; 2002 Apr; 4(2):112-8. PubMed ID: 11884266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Weight gain-induced blood pressure elevation.
    Masuo K; Mikami H; Ogihara T; Tuck ML
    Hypertension; 2000 May; 35(5):1135-40. PubMed ID: 10818077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertension in obesity and NIDDM. Role of insulin and sympathetic nervous system.
    Daly PA; Landsberg L
    Diabetes Care; 1991 Mar; 14(3):240-8. PubMed ID: 2044439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of sympathetic nervous system and neuropeptides in obesity hypertension.
    Hall JE; Brands MW; Hildebrandt DA; Kuo J; Fitzgerald S
    Braz J Med Biol Res; 2000 Jun; 33(6):605-18. PubMed ID: 10829088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular and renal complications of type 2 diabetes in obesity: role of sympathetic nerve activity and insulin resistance.
    Masuo K; Rakugi H; Ogihara T; Esler MD; Lambert GW
    Curr Diabetes Rev; 2010 Mar; 6(2):58-67. PubMed ID: 20034369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors that influence the risk of hypertension in obese individuals.
    Coatmellec-Taglioni G; Ribière C
    Curr Opin Nephrol Hypertens; 2003 May; 12(3):305-8. PubMed ID: 12698070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin resistance, energy balance and sympathetic nervous system activity.
    Landsberg L
    Clin Exp Hypertens A; 1990; 12(5):817-30. PubMed ID: 2208753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-mediated sympathetic stimulation: role in the pathogenesis of obesity-related hypertension (or, how insulin affects blood pressure, and why).
    Landsberg L
    J Hypertens; 2001 Mar; 19(3 Pt 2):523-8. PubMed ID: 11327624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropeptide Y and alpha-melanocyte-stimulating hormone: interaction in obesity and possible role in the development of hypertension.
    Baltatzi M; Hatzitolios A; Tziomalos K; Iliadis F; Zamboulis Ch
    Int J Clin Pract; 2008 Sep; 62(9):1432-40. PubMed ID: 18793378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sympathetic nervous system in obesity-related hypertension: mechanisms and clinical implications.
    Kalil GZ; Haynes WG
    Hypertens Res; 2012 Jan; 35(1):4-16. PubMed ID: 22048570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity-related hypertension: is there a role for selective leptin resistance?
    Correia ML; Haynes WG
    Curr Hypertens Rep; 2004 Jun; 6(3):230-5. PubMed ID: 15128477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperinsulinemia, insulin resistance, and hypertension.
    Bönner G
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S39-49. PubMed ID: 7898093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular and sympathetic effects of leptin.
    Rahmouni K; Haynes WG; Mark AL
    Curr Hypertens Rep; 2002 Apr; 4(2):119-25. PubMed ID: 11884267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity-hypertension: emerging concepts in pathophysiology and treatment.
    Mathew B; Patel SB; Reams GP; Freeman RH; Spear RM; Villarreal D
    Am J Med Sci; 2007 Jul; 334(1):23-30. PubMed ID: 17630587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hyperleptinemia as a risk factor in obesity-related hypertension].
    Alvarez-Aguilar C; Mondragón-Jiménez LI; Ramírez-Enríquez J; Gómez-García A; Paniagua-Sierra R; Amato D
    Med Clin (Barc); 2004 Dec; 123(20):766-9. PubMed ID: 15607067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex differences in sympathetic activity in obesity and its related hypertension.
    Fu Q
    Ann N Y Acad Sci; 2019 Oct; 1454(1):31-41. PubMed ID: 31087350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hypertension in obese patients: Pathophysiology and management].
    Girerd X; Hansel B
    Presse Med; 2009 Apr; 38(4):609-13. PubMed ID: 19233604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms in obesity-related hypertension: role of insulin and catecholamines.
    Krieger DR; Landsberg L
    Am J Hypertens; 1988 Jan; 1(1):84-90. PubMed ID: 3285861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sympathetic activity and body mass index contribute to blood pressure levels.
    Masuo K; Mikami H; Itoh M; Ogihara T; Tuck ML
    Hypertens Res; 2000 Jul; 23(4):303-10. PubMed ID: 10912765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neural mechanisms in human obesity-related hypertension.
    Rumantir MS; Vaz M; Jennings GL; Collier G; Kaye DM; Seals DR; Wiesner GH; Brunner-La Rocca HP; Esler MD
    J Hypertens; 1999 Aug; 17(8):1125-33. PubMed ID: 10466468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.